Adiponectin and risk of vascular events in the Northern Manhattan Study

Atherosclerosis

Volumn 226, Issue 2, 2013, Pages 483-489

  Gardener, Hannah ^a   Goldberg, Ronald ^a   Mendez, Armando J ^a   Wright, Clinton B ^a   Rundek, Tatjana ^a   Elkind, Mitchell S V ^b   Sacco, Ralph L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Adiponectin; Epidemiology; Myocardial infarction; Stroke

Indexed keywords

ADIPONECTIN;

ADULT; AGED; ARTICLE; CAUCASIAN; CEREBROVASCULAR ACCIDENT; FEMALE; HEALTH STATUS; HEART DEATH; HEART INFARCTION; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; UNITED STATES; WAIST CIRCUMFERENCE;

ADIPONECTIN; AFRICAN AMERICANS; AGED; BIOLOGICAL MARKERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; NEW YORK CITY; PROSPECTIVE STUDIES; RISK FACTORS; VASCULAR DISEASES;

EID: 84872379038     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.11.020     Document Type: Article

References (34)

1. Lara-Castro C., Fu Y., Chung B.H., Garvey W.T. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol 2007 Jun, 18(3):263-270.
2. Gardener H., Sjoberg C., Crisby M., et al. Adiponectin and carotid intima-media thickness in the Northern Manhattan Study. Stroke 2012 Apr, 43(4):1123-1125.
3. Kumada M., Kihara S., Sumitsuji S., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003 Jan 1, 23(1):85-89.
4. Frystyk J., Berne C., Berglund L., Jensevik K., Flyvbjerg A., Zethelius B. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab 2007 Feb, 92(2):571-576.
5. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. J Am Med Assoc 2004 Apr 14, 291(14):1730-1737.
6. Rajpathak S.N., Kaplan R.C., Wassertheil-Smoller S., et al. Resistin, but not adiponectin and leptin, is associated with the risk of ischemic stroke among postmenopausal women: results from the Women's Health Initiative. Stroke 2011 Jul, 42(7):1813-1820.
7. Matsumoto M., Ishikawa S., Kajii E. Association of adiponectin with cerebrovascular disease: a nested case-control study. Stroke 2008 Feb, 39(2):323-328.
8. Lawlor D.A., Davey Smith G., Ebrahim S., Thompson C., Sattar N. Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab 2005 Oct, 90(10):5677-5683.
9. Prugger C., Luc G., Haas B., et al. Adipocytokines and the risk of ischemic stroke: the PRIME Study. Ann Neurol 2012 Apr, 71(4):478-486.
10. Wannamethee S.G., Welsh P., Whincup P.H., et al. High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association?. Eur J Cardiovasc Prev Rehabil 2011 Feb, 18(1):65-71.
11. Wannamethee S.G., Whincup P.H., Lennon L., Sattar N. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Intern Med 2007 Jul 23, 167(14):1510-1517.
12. Dekker J.M., Funahashi T., Nijpels G., et al. Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab 2008 Apr, 93(4):1489-1496.
13. Kizer J.R., Barzilay J.I., Kuller L.H., Gottdiener J.S. Adiponectin and risk of coronary heart disease in older men and women. J Clin Endocrinol Metab 2008 Sep, 93(9):3357-3364.
14. Kanaya A.M., Wassel Fyr C., Vittinghoff E., et al. Serum adiponectin and coronary heart disease risk in older Black and White Americans. J Clin Endocrinol Metab 2006 Dec, 91(12):5044-5050.
15. Laughlin G.A., Barrett-Connor E., May S., Langenberg C. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol 2007 Jan 15, 165(2):164-174.
16. Silva F.M., de Almeida J.C., Feoli A.M. Effect of diet on adiponectin levels in blood. Nutr Rev 2011 Oct, 69(10):599-612.
17. Sacco R.L., Boden-Albala B., Abel G., et al. Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study. Stroke 2001 Aug, 32(8):1725-1731.
18. Wallman K.K., Hodgdon J. Race and ethnic standards for Federal statistics and administrative reporting. Stat Report 1977, (77-110):450-454.
19. Sacco R.L., Elkind M., Boden-Albala B., et al. The protective effect of moderate alcohol consumption on ischemic stroke. J Am Med Assoc 1999 Jan 6, 281(1):53-60.
20. Sacco R.L., Gan R., Boden-Albala B., et al. Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke 1998 Feb, 29(2):380-387.
21. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 Dec 17, 106(25):3143-3421.
22. Boden-Albala B., Sacco R.L., Lee H.S., et al. Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke 2008 Jan, 39(1):30-35.
23. Boden-Albala B., Cammack S., Chong J., et al. Diabetes, fasting glucose levels, and risk of ischemic stroke and vascular events: findings from the Northern Manhattan Study (NOMAS). Diabetes Care 2008 Jun, 31(6):1132-1137.
24. Sacco R.L., Khatri M., Rundek T., et al. Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study). J Am Coll Cardiol 2009 Dec 8, 54(24):2303-2311.
25. Sacco R.L., Boden-Albala B., Gan R., et al. Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol 1998 Feb 1, 147(3):259-268.
26. White H., Boden-Albala B., Wang C., et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation 2005 Mar 15, 111(10):1327-1331.
27. Van Berendoncks A.M., Garnier A., Beckers P., et al. Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure. Circ Heart Fail 2010 Mar, 3(2):185-194.
28. Bruce C.R., Mertz V.A., Heigenhauser G.J., Dyck D.J. The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes 2005 Nov, 54(11):3154-3160.
29. Mullen K.L., Smith A.C., Junkin K.A., Dyck D.J. Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats. Am J Physiol Endocrinol Metab 2007 Jul, 293(1):E83-E90.
30. Kotani K., Sakane N., Saiga K., Kurozawa Y. Leptin: adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes: relationship of the index to carotid intima-media thickness. Diabetologia 2005 Dec, 48(12):2684-2686.
31. Norata G.D., Raselli S., Grigore L., et al. Leptin: adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke 2007 Oct, 38(10):2844-2846.
32. Komura N., Kihara S., Sonoda M., et al. Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease. Circ J 2008 Jan, 72(1):23-28.
33. Pischon T., Hotamisligil G.S., Rimm E.B. Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clin Chem 2003 Apr, 49(4):650-652.
34. Gardener H, Crisby M, Sjoberg S, et al. Serum adiponectin in relation to race-ethnicity and vascular risk factors in the Northern Manhattan Study. Metab Syndr Relat Disord, in press.